Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

Related Articles by Review for PubMed (Select 15383474)

1.
2.

Antithrombotic therapy for coronary artery disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Harrington RA, Becker RC, Ezekowitz M, Meade TW, O'Connor CM, Vorchheimer DA, Guyatt GH.

Chest. 2004 Sep;126(3 Suppl):513S-548S. Review.

PMID:
15383483
4.
5.

Role of antiplatelet drugs in the prevention of cardiovascular events.

Tendera M, Wojakowski W.

Thromb Res. 2003 Jun 15;110(5-6):355-9. Review.

PMID:
14592562
6.

Antiplatelet agents and arterial thrombosis.

Billett HH.

Cardiol Clin. 2008 May;26(2):189-201, vi. doi: 10.1016/j.ccl.2007.12.007. Review.

PMID:
18406994
7.

Combined antithrombotic therapy for acute coronary syndrome.

Gawaz M, Müller I, Besta F.

Semin Vasc Med. 2003 May;3(2):163-76. Review.

PMID:
15199479
8.
9.

Clopidogrel and risk for acute coronary events.

Mood GR, Bhatt DL.

Curr Atheroscler Rep. 2007 Nov;9(5):401-8. Review.

PMID:
18001624
10.

Antiplatelet medications and their indications in preventing and treating coronary thrombosis.

Van De Graaff E, Steinhubl SR.

Ann Med. 2000 Nov;32(8):561-71. Review.

PMID:
11127934
11.

Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P.

Chest. 2004 Sep;126(3 Suppl):483S-512S. Review.

PMID:
15383482
12.

Antiplatelet therapy in early management of non-ST-segment elevation acute coronary syndrome: the 2002 and 2007 guidelines from North America and Europe.

Thomas D, Giugliano RP.

J Cardiovasc Pharmacol. 2008 May;51(5):425-33. doi: 10.1097/FJC.0b013e31816a35a2. Review.

PMID:
18418272
13.

Aspirin and clopidogrel: a sweeping combination in cardiology.

Manolis AS, Tzeis S, Andrikopoulos G, Koulouris S, Melita H.

Curr Med Chem Cardiovasc Hematol Agents. 2005 Jul;3(3):203-19. Review.

PMID:
15974885
14.

[Platelet aggregation inhibitors in diabetes mellitus].

Abrahamian H.

Acta Med Austriaca. 1999;26(5):137-41. Review. German.

PMID:
11512189
15.
16.

Antiplatelet agents.

Varon D, Spectre G.

Hematology Am Soc Hematol Educ Program. 2009:267-72. doi: 10.1182/asheducation-2009.1.267. Review.

17.

Role of clopidogrel in managing atherothrombotic cardiovascular disease.

Eshaghian S, Kaul S, Amin S, Shah PK, Diamond GA.

Ann Intern Med. 2007 Mar 20;146(6):434-41. Review.

PMID:
17371888
18.

Variability in responsiveness to oral antiplatelet therapy.

Angiolillo DJ.

Am J Cardiol. 2009 Feb 2;103(3 Suppl):27A-34A. doi: 10.1016/j.amjcard.2008.11.020. Review.

PMID:
19166710
19.

Antithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Clagett GP, Sobel M, Jackson MR, Lip GY, Tangelder M, Verhaeghe R.

Chest. 2004 Sep;126(3 Suppl):609S-626S. Review.

PMID:
15383487
20.

Combination antiplatelet agents for secondary prevention of ischemic stroke.

Vande Griend JP, Saseen JJ.

Pharmacotherapy. 2008 Oct;28(10):1233-42. doi: 10.1592/phco.28.10.1233. Review.

PMID:
18823219
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk